BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31810310)

  • 1. Development of a Phosphoric Acid-Mediated Hyaluronic Acid Gel Sheet for Efficient Transdermal Delivery of Alendronate for Anti-Osteoporotic Therapy.
    Naito C; Katsumi H; Yoneto K; Omura M; Nishidono M; Kamei S; Mizoguchi A; Tamba A; Tanaka A; Morishita M; Yamamoto A
    Pharmaceutics; 2019 Dec; 11(12):. PubMed ID: 31810310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient Transdermal Delivery of Alendronate, a Nitrogen-Containing Bisphosphonate, Using Tip-Loaded Self-Dissolving Microneedle Arrays for the Treatment of Osteoporosis.
    Katsumi H; Tanaka Y; Hitomi K; Liu S; Quan YS; Kamiyama F; Sakane T; Yamamoto A
    Pharmaceutics; 2017 Aug; 9(3):. PubMed ID: 28817072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous delivery of BMP-2 factor and anti-osteoporotic drugs using hyaluronan-assembled nanocomposite for synergistic regulation on the behaviors of osteoblasts and osteoclasts in vitro.
    Zhang Y; Hu Y; Luo Z; Shen X; Mu C; Cai K
    J Biomater Sci Polym Ed; 2015; 26(5):290-310. PubMed ID: 25585099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a novel self-dissolving microneedle array of alendronate, a nitrogen-containing bisphosphonate: evaluation of transdermal absorption, safety, and pharmacological effects after application in rats.
    Katsumi H; Liu S; Tanaka Y; Hitomi K; Hayashi R; Hirai Y; Kusamori K; Quan YS; Kamiyama F; Sakane T; Yamamoto A
    J Pharm Sci; 2012 Sep; 101(9):3230-8. PubMed ID: 22467424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a novel transdermal patch of alendronate, a nitrogen-containing bisphosphonate, for the treatment of osteoporosis.
    Kusamori K; Katsumi H; Abe M; Ueda A; Sakai R; Hayashi R; Hirai Y; Quan YS; Kamiyama F; Sakane T; Yamamoto A
    J Bone Miner Res; 2010 Dec; 25(12):2582-91. PubMed ID: 20533374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alendronate-decorated biodegradable polymeric micelles for potential bone-targeted delivery of vancomycin.
    Cong Y; Quan C; Liu M; Liu J; Huang G; Tong G; Yin Y; Zhang C; Jiang Q
    J Biomater Sci Polym Ed; 2015; 26(11):629-43. PubMed ID: 25994241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-Dissolving Microneedle Arrays for Transdermal Absorption Enhancement of Human Parathyroid Hormone (1-34).
    Naito C; Katsumi H; Suzuki T; Quan YS; Kamiyama F; Sakane T; Yamamoto A
    Pharmaceutics; 2018 Nov; 10(4):. PubMed ID: 30400376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering of Bone- and CD44-Dual-Targeting Redox-Sensitive Liposomes for the Treatment of Orthotopic Osteosarcoma.
    Feng S; Wu ZX; Zhao Z; Liu J; Sun K; Guo C; Wang H; Wu Z
    ACS Appl Mater Interfaces; 2019 Feb; 11(7):7357-7368. PubMed ID: 30682240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alendronate-loaded, biodegradable smart hydrogel: a promising injectable depot formulation for osteoporosis.
    Nafee N; Zewail M; Boraie N
    J Drug Target; 2018 Aug; 26(7):563-575. PubMed ID: 29073792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal delivery of fluvastatin loaded nanoemulsion gel: Preparation, characterization and in vivo anti-osteoporosis activity.
    Kaur R; Ajitha M
    Eur J Pharm Sci; 2019 Aug; 136():104956. PubMed ID: 31202895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alendronate loaded graphene oxide functionalized collagen sponge for the dual effects of osteogenesis and anti-osteoclastogenesis in osteoporotic rats.
    Zeng Y; Zhou M; Chen L; Fang H; Liu S; Zhou C; Sun J; Wang Z
    Bioact Mater; 2020 Dec; 5(4):859-870. PubMed ID: 32637749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained raloxifene release from hyaluronan-alendronate-functionalized titanium nanotube arrays capable of enhancing osseointegration in osteoporotic rabbits.
    Mu C; Hu Y; Huang L; Shen X; Li M; Li L; Gu H; Yu Y; Xia Z; Cai K
    Mater Sci Eng C Mater Biol Appl; 2018 Jan; 82():345-353. PubMed ID: 29025668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of an injectable depot system for long-term delivery of alendronate and evaluation of its anti-osteoporotic effect in an ovariectomized rat model.
    Bae J; Park JW
    Int J Pharm; 2015 Mar; 480(1-2):37-47. PubMed ID: 25595570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development and characteristics of novel microneedle arrays fabricated from hyaluronic acid, and their application in the transdermal delivery of insulin.
    Liu S; Jin MN; Quan YS; Kamiyama F; Katsumi H; Sakane T; Yamamoto A
    J Control Release; 2012 Aug; 161(3):933-41. PubMed ID: 22634072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and development of novel hyaluronate-modified nanoparticles for combo-delivery of curcumin and alendronate: fabrication, characterization, and cellular and molecular evidences of enhanced bone regeneration.
    Dong J; Tao L; Abourehab MAS; Hussain Z
    Int J Biol Macromol; 2018 Sep; 116():1268-1281. PubMed ID: 29782984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Injectable nanoparticle-loaded hydrogel system for local delivery of sodium alendronate.
    Posadowska U; Parizek M; Filova E; Wlodarczyk-Biegun M; Kamperman M; Bacakova L; Pamula E
    Int J Pharm; 2015 May; 485(1-2):31-40. PubMed ID: 25747455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual targeted zeolitic imidazolate framework nanoparticles for treating metastatic breast cancer and inhibiting bone destruction.
    Shen Y; Lv Y
    Colloids Surf B Biointerfaces; 2022 Nov; 219():112826. PubMed ID: 36115265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A preliminary study on the morphological and release properties of hydroxyapatite-alendronate composite materials.
    Capra P; Dorati R; Colonna C; Bruni G; Pavanetto F; Genta I; Conti B
    J Microencapsul; 2011; 28(5):395-405. PubMed ID: 21736524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro/ex vivo evaluation of multifunctional collagen/chitosan/hyaluronic acid hydrogel-based alendronate delivery systems.
    Klara J; Hinz A; Bzowska M; Horak W; Lewandowska-Łańcucka J
    Int J Biol Macromol; 2024 Mar; 262(Pt 2):130142. PubMed ID: 38365151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alendronate-loaded hydroxyapatite-TiO
    Shen X; Ma P; Hu Y; Xu G; Xu K; Chen W; Ran Q; Dai L; Yu Y; Mu C; Cai K
    J Mater Chem B; 2016 Feb; 4(8):1423-1436. PubMed ID: 32263109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.